Technical Analysis for HOOK - HOOKIPA Pharma Inc.

Grade Last Price % Change Price Change
D 0.71 -1.17% -0.01
HOOK closed down 1.17 percent on Thursday, March 28, 2024, on 72 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down

Date Alert Name Type % Chg
Inside Day Range Contraction -1.17%
Earnings Movers Other -0.97%
Inside Day Range Contraction -0.97%
50 DMA Support Bullish 1.34%
Earnings Movers Other 1.34%
Gapped Up Strength 1.34%
20 DMA Resistance Bearish 0.13%
Gapped Up Strength 0.13%
NR7 Range Contraction -1.67%
NR7-2 Range Contraction -1.67%

   Recent Intraday Alerts

Alert Time
10 DMA Support about 9 hours ago
Rose Above Previous Day's High about 9 hours ago
1.5x Volume Pace about 9 hours ago
Up 2% about 9 hours ago
Down 1% about 10 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

HOOKIPA Pharma Inc. Description

HOOKIPA Pharma Inc., a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop arenavirus based therapeutics to treat hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Infectious Diseases Hepatitis B Transplantation Immunodeficiency Hepatitis B Virus Viral Disease Papillomavirus Gilead Sciences Immunotherapeutics Kidney Transplant

Is HOOK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.05
52 Week Low 0.41
Average Volume 524,126
200-Day Moving Average 0.68
50-Day Moving Average 0.70
20-Day Moving Average 0.74
10-Day Moving Average 0.72
Average True Range 0.05
RSI (14) 48.45
ADX 11.69
+DI 16.88
-DI 14.37
Chandelier Exit (Long, 3 ATRs) 0.71
Chandelier Exit (Short, 3 ATRs) 0.80
Upper Bollinger Bands 0.81
Lower Bollinger Band 0.67
Percent B (%b) 0.29
BandWidth 18.54
MACD Line 0.00
MACD Signal Line 0.01
MACD Histogram -0.0051
Fundamentals Value
Market Cap 68.74 Million
Num Shares 96.6 Million
EPS -0.80
Price-to-Earnings (P/E) Ratio -0.89
Price-to-Sales 3.25
Price-to-Book 0.70
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.76
Resistance 3 (R3) 0.76 0.75 0.75
Resistance 2 (R2) 0.75 0.74 0.75 0.75
Resistance 1 (R1) 0.73 0.73 0.73 0.73 0.74
Pivot Point 0.72 0.72 0.72 0.72 0.72
Support 1 (S1) 0.70 0.71 0.70 0.70 0.68
Support 2 (S2) 0.69 0.70 0.69 0.68
Support 3 (S3) 0.67 0.69 0.67
Support 4 (S4) 0.67